Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 675 participants.

Also called NCT04246450

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 675 participants (planned count) (from the registry)
Sponsor
University of Athens (from the registry)
Registry
  • NCT NCT04246450
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Greece (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04246450. Non-randomized; no masking; primary purpose prevention. Start 2020-09-01 (actual); primary completion 2025-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy
Acronym
ReCONSIDER
Condition
Sudden Cardiac Death Due to Cardiac Arrhythmia
Condition
Dilated Cardiomyopathy
Intervention (Device)
Implantable Cardioverter Defibrillator (ICD) insertion
Lead sponsor
University of Athens (class: other)

Record details

Record id
cardio:ct-nct04246450
Content hash
9834f12d97adb4a84f1964a86cbe8b19f8dfee61fb0900ffd64eefd3dc4ef34d